4.3 Review

Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art

Journal

EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Volume 14, Issue 1, Pages 79-93

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17512433.2021.1863784

Keywords

Cardiovascular disease; fatty acid metabolism; omega-3 polyunsaturated fatty acids; reduce-IT; strength

Ask authors/readers for more resources

This article reviews the roles of omega-3 polyunsaturated fatty acids in cardiovascular diseases, including their anti-inflammatory effects and specialized preparations for treatment. Various trials on the cardiovascular protective effects of omega-3 PUFAs have reported inconsistent results, possibly due to dosage and trial design issues.
Introduction: An epidemiological study of Greenlandic Inuit suggested the importance of omega-3 polyunsaturated fatty acids (PUFAs) in preventing ischemic heart disease. After this landmark study, large-scale epidemiological studies have examined the benefits of omega-3 PUFAs in the prevention of cardiovascular diseases. Areas covered: This article reviews studies on omega-3 PUFAs, and identifies issues relevant to cardiovascular risk. Expert opinion: Recent studies have focused on the anti-inflammatory effects of omega-3 PUFAs and specialized pro-resolving mediators. High-purity eicosapentaenoic acid (EPA) ethyl ester and EPA/docosahexaenoic acid (DHA) preparations have been developed primarily for the treatment of hypertriglyceridemia. Various trials on the cardiovascular protective effects of omega-3 PUFAs have been reported, but the results have not been consistent. Some issues of the trials have been suggested, such as using low-dose omega-3 PUFAs and not including hypertriglyceridemia in subject selection criteria. REDUCE-IT study that used a high dose of high-purity EPA preparation showed a relative reduction in cardiovascular events, but, the STRENGTH study that used a high dose of EPA/DHA preparation did not support this benefit. This article reviews the roles of omega-3 PUFAs in cardiovascular diseases, including progress in understanding the molecular mechanisms and recent large-scale clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Issue of Waist Circumference for the Diagnosis of Metabolic Syndrome Regarding Arterial Stiffness: Possible Utility of a Body Shape Index in Middle-Aged Nonobese Japanese Urban Residents Receiving Health Screening

Daiji Nagayama, Yasuhiro Watanabe, Takashi Yamaguchi, Kenji Suzuki, Atsuhito Saiki, Kentaro Fujishiro, Kohji Shirai

Summary: This cross-sectional study found that using ABSI to diagnose MetS can better identify individuals at risk of arterial stiffening compared to using waist circumference and body mass index. ABSI can help assess the risk of cardiovascular disease more effectively.

OBESITY FACTS (2022)

Article Endocrinology & Metabolism

Preoperative Plasma Aldosterone Predicts Complete Remission of Type 2 Diabetes after Bariatric Surgery

Masahiro Ohira, Kazuki Abe, Takashi Yamaguchi, Hiroki Onda, Shuhei Yamaoka, Shoko Nakamura, Shou Tanaka, Yasuhiro Watanabe, Taiki Nabekura, Takashi Oshiro, Daiji Nagayama, Atsuhito Saiki, Ichiro Tatsuno

Summary: This study aimed to evaluate the relationship between the improvement in type 2 diabetes and hormones in patients with obesity and type 2 diabetes who underwent bariatric surgery (BS). The results showed that preoperative plasma aldosterone levels were related to complete remission (CR) of type 2 diabetes after BS, and measuring plasma aldosterone levels preoperatively is useful for predicting the CR of type 2 diabetes after BS.

OBESITY FACTS (2022)

Article Endocrinology & Metabolism

Characteristics of Childhood Onset and Post-Puberty Onset Obesity and Weight Regain after Laparoscopic Sleeve Gastrectomy in Japanese Subjects: A Subgroup Analysis of J-SMART

Yasuhiro Watanabe, Takashi Yamaguchi, Sho Tanaka, Akira Sasaki, Takeshi Naitoh, Hisahiro Matsubara, Koutaro Yokote, Shinichi Okazumi, Satoshi Ugi, Hiroshi Yamamoto, Masayuki Ohta, Yasushi Ishigaki, Kazunori Kasama, Yosuke Seki, Motoyoshi Tsujino, Kohji Shirai, Yasuhiro Miyazaki, Takayuki Masaki, Daiji Nagayama, Atushito Saiki, Ichiro Tatsuno

Summary: This study investigates the psychosocial background and outcomes after bariatric surgery in subjects with childhood onset obesity (CO). The results suggest that CO may be associated with genetic and psychosocial factors, and CO and post-puberty onset obesity (PPO) may differ in pathogenesis and require different treatment strategies.

OBESITY FACTS (2022)

Article Endocrinology & Metabolism

Soluble (Pro)Renin Receptor Level in Patients with Severe Obesity Is Associated with Visceral Adiposity and Is Involved with Insulin Resistance and Renal Injury

Takashi Yamaguchi, Satoshi Morimoto, Chikahito Suda, Atsuhiro Ichihara, Noriko Ishihara, Shoko Nakamura, Sho Tanaka, Yasuhiro Watanabe, Haruki Imamura, Masahiro Ohira, Naomi Shimizu, Atsuhito Saiki, Ichiro Tatsuno

Summary: This study examined the relationship between soluble (pro)renin receptor (s[P]RR) levels and body composition and metabolic factors in severely obese patients who underwent laparoscopic sleeve gastrectomy (LSG). The results showed that blood s(P)RR levels were high in these patients and decreased after weight loss through LSG. The study suggests that blood s(P)RR levels in obese patients may be associated with visceral fat and play a role in insulin resistance and renal damage mechanisms associated with obesity.

OBESITY FACTS (2023)

Article Endocrinology & Metabolism

Factors associated with relapse of type 2 diabetes mellitus after laparoscopic sleeve gastrectomy in Japanese subjects: a subgroup analysis of J-SMART study

Yasuhiro Watanabe, Takashi Yamaguchi, Daiji Nagayama, Sho Tanaka, Akira Sasaki, Takeshi Naitoh, Hisahiro Matsubara, Koutaro Yokote, Shinichi Okazumi, Satoshi Ugi, Hiroshi Yamamoto, Masayuki Ohta, Yasushi Ishigaki, Kazunori Kasama, Yosuke Seki, Motoyoshi Tsujino, Kohji Shirai, Yasuhiro Miyazaki, Takayuki Masaki, Atsuhito Saiki, Ichiro Tatsuno

Summary: A study on 322 Japanese subjects showed that 83.0% of the patients achieved HbA1c level <7% after LSG surgery, but 26.8% experienced diabetes relapse. Preoperative HbA1c, weight loss after surgery, and weight regain were identified as important factors contributing to diabetes relapse.

OBESITY FACTS (2023)

Article Endocrinology & Metabolism

Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy

Masahiro Ohira, Yasuhiro Watanabe, Takashi Yamaguchi, Hiroki Onda, Shuhei Yamaoka, Kazuki Abe, Shoko Nakamura, Sho Tanaka, Naoyuki Kawagoe, Taiki Nabekura, Takashi Oshiro, Daiji Nagayama, Ichiro Tatsuno, Atsuhito Saiki

Summary: Following laparoscopic sleeve gastrectomy (LSG), obese patients experienced significant increases in high-density lipoprotein cholesterol (HDL-C) levels and pre-heparin lipoprotein lipase (LPL) levels, while body mass index (BMI) and serum triglyceride (TG) levels decreased significantly. Simple linear regression analysis revealed a significant correlation between changes in HDL-C levels and total weight loss percentage, change in TG levels, abdominal fat areas, and pre-heparin LPL levels. Multiple regression analysis further indicated that the increase in HDL-C levels after LSG was associated with reductions in TG levels and elevations in pre-heparin LPL levels.

OBESITY FACTS (2021)

Article Endocrinology & Metabolism

The Relationship between Serum Insulin-Like Growth Factor-1 Levels and Body Composition Changes after Sleeve Gastrectomy

Masahiro Ohira, Yasuhiro Watanabe, Takashi Yamaguchi, Hiroki Onda, Shuhei Yamaoka, Kazuki Abe, Shoko Nakamura, Shou Tanaka, Naoyuki Kawagoe, Taiki Nabekura, Atsuhito Saiki, Takashi Oshiro, Daiji Nagayama, Ichiro Tatsuno

Summary: The preoperative measurement of IGF-1 can help predict successful weight loss, decrease body fat mass, and maintain skeletal muscle mass after LSG.

OBESITY FACTS (2021)

Article Endocrinology & Metabolism

Effect of Conventional Medical Therapy or Laparoscopic Sleeve Gastrectomy on Urinary Albumin in Japanese Subjects with Severe Obesity: An Observational Study

Yasuhiro Watanabe, Takashi Yamaguchi, Shuhei Yamaoka, Kazuki Abe, Hiroki Onda, Shoko Nakamura, Sho Tanaka, Takashi Oshiro, Masahiro Ohira, Daiji Nagayama, Naomi Shimizu, Ichiro Tatsuno, Atsuhito Saiki

Summary: This study compared the impact of weight loss achieved through conventional medical therapy or laparoscopic sleeve gastrectomy (LSG) on albuminuria in Japanese subjects with severe obesity. The results showed that the LSG group had greater weight loss, lower glycosylated hemoglobin levels, and more significant improvement in albuminuria compared to the medical therapy group.

OBESITY FACTS (2021)

No Data Available